Cargando…

The impact of COVID-19 on compliance to amblyopia treatment in a tertiary eye care center

PURPOSE: To investigate the impact of the coronavirus disease 2019 (COVID-19) outbreak on compliance to amblyopia therapy from the perspective of parents of amblyopic children. METHODS: The participants for the qualitative study were enrolled from the medical records of a tertiary eye care center du...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegde, Namratha, Vidya, C, Bandamwar, Kalika, Murali, Kaushik, Murthy, Sowmya Raveendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391401/
https://www.ncbi.nlm.nih.gov/pubmed/37203090
http://dx.doi.org/10.4103/ijo.IJO_2135_22
Descripción
Sumario:PURPOSE: To investigate the impact of the coronavirus disease 2019 (COVID-19) outbreak on compliance to amblyopia therapy from the perspective of parents of amblyopic children. METHODS: The participants for the qualitative study were enrolled from the medical records of a tertiary eye care center during the COVID-19 pandemic. The trained researcher conducted telephonic interviews consisting of validated 15 open-ended questions for 15 min. The questions were related to patients’ compliance toward amblyopia treatment and the date of follow-up with their practitioners. The data collected were entered on Excel sheets in the participant’s own words and later converted to a transcript for analysis. RESULTS: A total of 217 parents of children with amblyopia who were due for follow-up were contacted through telephone. The response rate for willingness to participate was only 36% (n = 78). Of these, 76% (n = 59) of parents reported that their child was compliant toward the treatment during the therapy period and 69% reported that their child was currently not on treatment for amblyopia. CONCLUSION: In the current study, we have observed that although reported compliance by parents during the therapy period was good, around 69% of patients had discontinued amblyopia therapy. The main reason for the discontinuation of therapy was the failure to visit the hospital during the scheduled follow-up with the eye care practitioner.